THERA integrated platform
Theramix is creating an integrated system of diagnosis, therapy and molecular imaging.
At Theramix, molecular imaging is incorporated into the whole process of discovery. It appears in every decision-making steps including validation of targets, staging of diseases, evaluation of engagement and efficacy of drugs. |
THERA target mapping
With the major focus on targeting the extracellular microenvironment, Theramix developed quantitative mapping technology to identify extracellular molecules as drug targets and biomarkers for diagnosis. We're developing new diagnostics for early detection and staging of cancer based on the signature information from the target maps.
|
|
|
